verapamil has been researched along with carnitine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (25.00) | 18.7374 |
| 1990's | 6 (25.00) | 18.2507 |
| 2000's | 6 (25.00) | 29.6817 |
| 2010's | 6 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nezu, J; Oku, A; Sai, Y; Sakamoto, K; Shimane, M; Tamai, I; Tsuji, A; Yabuuchi, H | 1 |
| Nezu, JI; Ohashi, R; Oku, A; Sai, Y; Shimane, M; Tamai, I; Tsuji, A; Yabuuchi, H | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Criddle, DN; Dewar, GH; Wathey, WB; Woodward, B | 1 |
| Fellenius, E; Ichihara, K; Mjøs, OD; Myrmel, T; Neely, JR | 1 |
| Danilovich, MI; Dunaev, VV; Favoritov, VN; Kacharava, VG; Kryzhanovskiĭ, SA; Riabinin, VA; Tishkin, VS | 1 |
| Mir, AK; Spedding, M | 1 |
| Boscoboinik, D; Epand, RM | 1 |
| Bettini, V; Catozzo, C; Martino, R; Mayellaro, F; Munari, L; Tegazzin, V; Ton, P | 1 |
| Kobayashi, A; Miura, K; Shirasawa, H; Yamashita, T; Yamazaki, N | 1 |
| Abe, M; Hayashi, H; Ishizaka, K; Kamikawa, T; Kobayashi, A; Nagao, B; Nishiyama, T; Yamashita, T; Yamazaki, N | 1 |
| Bartoli Klugmann, F; Decorti, G; Klugmann, S | 1 |
| Blanchard, J; Giuliano, AR; Nguyen, LD; Surendran, N | 1 |
| Biagiotti, G; Cavallini, G; Koverech, A; Vitali, G | 1 |
| Cavallini, G | 1 |
| Fukami, T; Furuishi, T; Moriki, Y; Suzuki, T; Tomono, K; Watanabe, J | 1 |
| Amat di San Filippo, C; Longo, N; Pasquali, M | 1 |
| Kato, Y; Kubo, Y; Sugiura, T; Tsuji, A | 1 |
| Bania, T; Chu, J; Medlej, K; Perez, E | 1 |
| Agu, RU; Macdonald, C; Oli, A; Shao, D | 1 |
| Carson, CC; Jordan, GH; Lipshultz, LI | 1 |
2 review(s) available for verapamil and carnitine
| Article | Year |
|---|---|
Towards an evidence-based understanding of Peyronie's disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Carnitine; Evidence-Based Medicine; Fibroblasts; Humans; Male; Middle Aged; Penile Induration; Penis; Verapamil | 2005 |
Minimally invasive treatment of Peyronie's disease: evidence-based progress.
Topics: 4-Aminobenzoic Acid; Administration, Oral; Calcium Channel Blockers; Carnitine; Colchicine; Evidence-Based Medicine; Humans; Injections, Intralesional; Interferon-alpha; Iontophoresis; Lithotripsy; Male; Microbial Collagenase; Nicardipine; Penile Induration; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome; Verapamil; Vitamin E | 2014 |
1 trial(s) available for verapamil and carnitine
| Article | Year |
|---|---|
Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Carnitine; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Humans; Injections, Intralesional; Male; Middle Aged; Penile Induration; Prospective Studies; Verapamil | 2002 |
21 other study(ies) available for verapamil and carnitine
| Article | Year |
|---|---|
Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations.
Topics: Animals; Biological Transport, Active; Carrier Proteins; Cell Line; Gene Expression; Humans; Hydrogen-Ion Concentration; Membrane Potentials; Membrane Proteins; Membrane Transport Proteins; Oocytes; Organic Cation Transport Proteins; Quinidine; RNA, Messenger; Symporters; Tetraethylammonium Compounds; Xenopus laevis | 1999 |
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
Topics: Biological Transport, Active; Carnitine; Carrier Proteins; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Hydrogen-Ion Concentration; Kidney; Membrane Proteins; Organic Cation Transport Proteins; Sodium; Solute Carrier Family 22 Member 5; Stereoisomerism | 1999 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
The effects of novel vasodilator long chain acyl carnitine esters in the isolated perfused heart of the rat.
Topics: Animals; Benzopyrans; Carnitine; Coronary Circulation; Cromakalim; Dose-Response Relationship, Drug; Epoprostenol; Heart; Iloprost; In Vitro Techniques; Male; Myocardial Contraction; Nitrates; Palmitoylcarnitine; Pentanols; Pyrroles; Rats; Rats, Inbred Strains; Vasodilator Agents; Verapamil | 1990 |
Fatty acids suppress recovery of heart function after hypothermic perfusion.
Topics: Acyl Coenzyme A; Adenosine Triphosphate; Animals; Calcium; Carnitine; Coronary Circulation; Fatty Acids; Glycine; Heart Arrest, Induced; Hypothermia, Induced; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Myocardium; Palmitates; Phosphocreatine; Rats; Rats, Inbred Strains; Ventricular Function, Left; Verapamil | 1991 |
[Study of anti-ischemic action of carnitine chloride and its effects on the effectiveness of antianginal agents].
Topics: Animals; Carnitine; Cats; Clinical Enzyme Tests; Drug Therapy, Combination; Myocardial Infarction; Myocardium; Nitroglycerin; Rats; Rats, Inbred Strains; Verapamil | 1990 |
Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand.
Topics: Animals; Binding, Competitive; Calcium Channel Blockers; Carnitine; Cerebral Cortex; Detergents; Guinea Pigs; In Vitro Techniques; Ion Channels; Male; Membranes; Muscle, Smooth; Palmitoylcarnitine; Rats; Rats, Inbred Strains; Verapamil | 1987 |
Increased cellular internalization of amphiphiles in a multidrug-resistant CHO cell line.
Topics: Animals; Biological Transport; Carnitine; Cell Line; Cell Membrane; Cricetinae; Cyclosporins; Diffusion; Drug Resistance; Kinetics; Lysophosphatidylcholines; Palmitoylcarnitine; Quinacrine; Solubility; Verapamil | 1989 |
[Changes in acetylcholine contractions induced by carnitine in coronary vessels isolated "in vitro"].
Topics: Acetylcholine; Animals; Atropine; Calcium; Carnitine; Cattle; Coronary Vessels; Fendiline; In Vitro Techniques; Kinetics; Muscle Contraction; Pyrrolidines; Receptors, Muscarinic; Verapamil | 1985 |
Effects of L-carnitine and verapamil on myocardial carnitine concentration and histopathology of Syrian hamster BIO 14.6.
Topics: Animals; Calcinosis; Cardiomyopathies; Carnitine; Cricetinae; Fibrosis; Mesocricetus; Myocardium; Necrosis; Verapamil | 1986 |
Antiarrhythmic and myocardial metabolic effects of verapamil during coronary artery reperfusion.
Topics: Acyl Coenzyme A; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Carnitine; Coronary Vessels; Dogs; Fatty Acids, Nonesterified; Female; Male; Myocardium; Perfusion; Verapamil | 1985 |
[Myocardial disease caused by adriamycin. Experimental animal models and possible pharmacologic prevention].
Topics: Animals; Cardiomyopathies; Carnitine; Disease Models, Animal; Doxorubicin; Mice; Rabbits; Rats; Razoxane; Verapamil | 1982 |
Mechanisms of acylcarnitine-mediated enhancement of calcium transport in the Caco-2 cell monolayer model.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Biological Transport; Calcium; Calcium Channels; Carnitine; Cell Line; Dose-Response Relationship, Drug; Kinetics; Nifedipine; Time Factors; Verapamil | 1995 |
In vivo evidence for the efflux transport of pentazocine from the brain across the blood-brain barrier using the brain efflux index method.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Carbon Radioisotopes; Carnitine; Dose-Response Relationship, Drug; Drug Carriers; Drug Evaluation, Preclinical; Half-Life; Inulin; Male; Microinjections; Pentazocine; Quinidine; Rats; Rats, Wistar; Tetraethylammonium; Tritium; Verapamil | 2005 |
Pharmacological rescue of carnitine transport in primary carnitine deficiency.
Topics: Adult; Animals; Biological Transport; Carnitine; Child, Preschool; CHO Cells; Cricetinae; Cricetulus; Curcumin; DNA Mutational Analysis; DNA, Complementary; Endoplasmic Reticulum; Enzyme Inhibitors; Female; Humans; Infant; Male; Mutation, Missense; Organic Cation Transport Proteins; Phenylbutyrates; Quinidine; Solute Carrier Family 22 Member 5; Verapamil; Vitamin B Deficiency | 2006 |
Mutation in an adaptor protein PDZK1 affects transport activity of organic cation transporter OCTNs and oligopeptide transporter PEPT2.
Topics: Adaptor Protein Complex gamma Subunits; Biological Transport; Carbon Radioisotopes; Carnitine; Carrier Proteins; Cell Line; Cell Membrane; Dipeptides; Humans; Membrane Proteins; Mutation; Organic Cation Transport Proteins; Organic Cation Transporter 1; Protein Binding; Pyrilamine; Solute Carrier Family 22 Member 5; Symporters; Tetraethylammonium; Transfection; Tritium; Two-Hybrid System Techniques; Verapamil | 2006 |
L-carnitine increases survival in a murine model of severe verapamil toxicity.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Carnitine; Disease Models, Animal; Infusions, Intravenous; Male; Rats; Rats, Sprague-Dawley; Shock, Cardiogenic; Verapamil | 2011 |
Characterization of Calu-3 cell monolayers as a model of bronchial epithelial transport: organic cation interaction studies.
Topics: Biological Transport, Active; Bronchi; Carnitine; Cell Line; Corticosterone; Epithelial Cells; Fluorescent Dyes; Gene Expression Regulation; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Methylamines; Microscopy, Fluorescence; Models, Biological; Organic Cation Transport Proteins; Polymerase Chain Reaction; Pyridinium Compounds; Temperature; Verapamil | 2013 |